As of 2024-12-12, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.15) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -850.2%.
The range of the Relative Valuation is (0.10) - (0.11) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 6.9x | 4.6x |
| Forward P/E multiples | 1.7x - 2.5x | 2.1x |
| Fair Price | (0.10) - (0.11) | (0.15) |
| Upside | -619.6% - -664.4% | -850.2% |
| Date | P/E |